Cancer Therapeutics

In addition to our commercial contract work, the Cancer Therapeutics Department has been involved with numerous National Cancer Institute (NCI) grants and contracts over the years either as principal investigator or core laboratory. Listed below are our current NCI grants:

R01-CA124952 - 4'-Substituted Nucleoside Analogs as Anticancer Drugs
R01-CA119170 - Tumor Sensitization to Purine Analogs by E. coli PNP
P01-CA94000 - Rational Design of Inhibitors of Polyamine Synthesis

We would like to be part of your NCI grant or contract application.